Japan

J&J Vision and Menicon Tackle Myopia with Contact Lens Collaboration
J&J Vision and Menicon Tackle Myopia with Contact Lens Collaboration
Medical Devices and Diagnostics Industry
JNJ
Menicon
myopia
contact lens
Japan
devices
Medtech
Flag link:
Daiichi takes mRNA COVID-19 vaccine into clinic as Japanese R&D belatedly fires up
Daiichi takes mRNA COVID-19 vaccine into clinic as Japanese R&D belatedly fires up
Fierce Biotech
Daiichi Sankyo
MRNA
COVID-19
vaccines
Japan
Flag link:
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
Motley Fool
Merck
AstraZeneca
Japan
ovarian cancer
prostate cancer
pancreatic cancer
Lynparza
Flag link:
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Endpoints
Takeda
gene editing
Japan
AnGes
EmendoBio
Flag link:
Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis
Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis
Pharmaceutical Business Review
Astellas
FibroGen
Japan
Evrenzo
chronic kidney disease
Flag link:
Game on: Pfizer, BioNTech prepare to put COVID-19 shot distribution plan to the test after interim readout
Game on: Pfizer, BioNTech prepare to put COVID-19 shot distribution plan to the test after interim readout
Fierce Pharma
Pfizer
BioNTech
drug manufacturing
vaccines
COVID-19
Italy
Japan
Flag link:
Poxel posts phase 3 diabetes data ahead of approval decision
Poxel posts phase 3 diabetes data ahead of approval decision
Fierce Biotech
Poxel
diabetes
clinical trials
imeglimin
Japan
Flag link:
Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan
Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan
Motley Fool
Moderna Therapeutics
Japan
Takeda
vaccines
COVID-19
Flag link:
Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown
Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown
Fierce Pharma
Takeda
Japan
early retirement
Shire
M&A
Flag link:
FDA gives speedy approval to another Duchenne drug
FDA gives speedy approval to another Duchenne drug
BioPharma Dive
FDA
NS Pharma
Japan
Duchenne Muscular Dystrophy
Viltepso
viltolarsen
Flag link:
Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan
Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan
Motley Fool
Novavax
Japan
vaccines
Takeda
COVID-19
NVX-CoV2373
Flag link:
Pfizer, BioNTech score deal to supply 120M Covid-19 vaccine doses to Japan
Pfizer, BioNTech score deal to supply 120M Covid-19 vaccine doses to Japan
MedCity News
Pfizer
BioNTech
Japan
vaccines
COVID-19
Flag link:
Teva, Takeda offload generics, manufacturing plant to Nichi-Iko in Japanese venture reshuffle
Teva, Takeda offload generics, manufacturing plant to Nichi-Iko in Japanese venture reshuffle
Fierce Pharma
Teva Pharmaceutical
Takeda
Japan
generics
drug manufacturing
Flag link:
Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan
Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan
Pharmaforum
Eisai
Dayvigo
Japan
insomnia
Merck
Belsomra
Flag link:
GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival
GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival
Pharmaforum
GSK
anemia
chronic kidney disease
daprodustat
Japan
Astellas
Kyowa Kirin
Flag link:
AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful
AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful
Fierce Pharma
AstraZeneca
Daiichi Sankyo
University of Oxford
vaccines
COVID-19
Japan
Flag link:
Sosei pens inflammatory and autoimmune disease drug pact with AbbVie
Sosei pens inflammatory and autoimmune disease drug pact with AbbVie
Fierce Biotech
Sosei Heptares
AbbVie
Japan
drug discovery
Flag link:
Takeda posts surprise profit a year after Shire mega-merger
Takeda posts surprise profit a year after Shire mega-merger
Pharmaforum
Japan
Takeda
Shire
M&A
earnings
Flag link:
Japan approves Gilead Sciences' remdesivir as COVID-19 drug
Japan approves Gilead Sciences' remdesivir as COVID-19 drug
Reuters
Japan
Gilead Sciences
COVID-19
remdesivir
Flag link:
Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report
Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report
Fierce Biotech
Japan
Gilead Sciences
remdesivir
COVID-19
Flag link:

Pages